Search research articles
Contact Us
Filters
Showing results (251-260 of 298) with videos related to
Page
of 30
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 9, 2019
Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Donal McLornan, Richard Szydlo, Linda Koster, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 7, 2016
Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research
Victoria T Potter, Simona Iacobelli, Anja van Biezen, et al.
Haematologica
|
January 19, 2019
Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis
Marie Robin, Sylvie Chevret, Linda Koster, et al.
Bone Marrow Transplantation
|
March 16, 2024
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
Marie Robin, Simona Iacobelli, Linda Koster, et al.
Haematologica
|
February 9, 2019
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Marie Robin, Liesbeth C de Wreede, Christine Wolschke, et al.
Bone Marrow Transplantation
|
January 22, 2024
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
María Queralt Salas, Diderik-Jan Eikema, Linda Koster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2024
Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies
Esteban Arrieta-Bolaños, Edouard F Bonneville, Pietro Crivello, et al.
The Lancet. Haematology
|
December 9, 2022
Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT
Nicola Polverelli, Juan Carlos Hernández-Boluda, Tomasz Czerw, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 2, 2019
Comparison of Dynamic International Prognostic Scoring System and MYelofibrosis SECondary to PV and ET Prognostic Model for Prediction of Outcome in Polycythemia Vera and Essential Thrombocythemia Myelofibrosis after Allogeneic Stem Cell Transplantation
Nico Gagelmann, Diderik-Jan Eikema, Liesbeth C de Wreede, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 31, 2012
Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies
Gandhi Damaj, Alain Duhamel, Marie Robin, et al.
Page
of 30
Search research articles
Search
Showing results (251-260 of 298) with videos related to
Sort By:
Page
of 30
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 9, 2019
Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Donal McLornan, Richard Szydlo, Linda Koster, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 7, 2016
Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research
Victoria T Potter, Simona Iacobelli, Anja van Biezen, et al.
Haematologica
|
January 19, 2019
Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis
Marie Robin, Sylvie Chevret, Linda Koster, et al.
Bone Marrow Transplantation
|
March 16, 2024
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
Marie Robin, Simona Iacobelli, Linda Koster, et al.
Haematologica
|
February 9, 2019
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Marie Robin, Liesbeth C de Wreede, Christine Wolschke, et al.
Bone Marrow Transplantation
|
January 22, 2024
Impact of post-transplant cyclophosphamide (PTCy)-based prophylaxis in matched sibling donor allogeneic haematopoietic cell transplantation for patients with myelodysplastic syndrome: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
María Queralt Salas, Diderik-Jan Eikema, Linda Koster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2024
Human Leukocyte Antigen Mismatching and Survival in Contemporary Hematopoietic Cell Transplantation for Hematologic Malignancies
Esteban Arrieta-Bolaños, Edouard F Bonneville, Pietro Crivello, et al.
The Lancet. Haematology
|
December 9, 2022
Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT
Nicola Polverelli, Juan Carlos Hernández-Boluda, Tomasz Czerw, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 2, 2019
Comparison of Dynamic International Prognostic Scoring System and MYelofibrosis SECondary to PV and ET Prognostic Model for Prediction of Outcome in Polycythemia Vera and Essential Thrombocythemia Myelofibrosis after Allogeneic Stem Cell Transplantation
Nico Gagelmann, Diderik-Jan Eikema, Liesbeth C de Wreede, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 31, 2012
Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies
Gandhi Damaj, Alain Duhamel, Marie Robin, et al.
Page
of 30